— Know what they know.
Not Investment Advice

NVRO NYSE

Nevro Corp.
1W: -0.2% 1M: +1.9% 3M: +57.0% 1Y: -56.2% 3Y: -91.3% 5Y: -93.5%
$5.84
Last traded 2025-04-02 — delisted
NYSE · Healthcare · Medical - Devices · $224.1M mcap · 34M float · 3.80% daily turnover · Short 35% of daily vol

📊 Key Metrics

TTM
$409M
Revenue
-3.9% YoY
$-113M
Net Income
-23.0% YoY
$-29M
Free Cash Flow
+59.7% YoY
62.5%
Gross Margin
-48.7%
Op. Margin
-50.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-43.3%
ROA-19.1%
ROIC-51.1%

Valuation

P/E-1.9
P/B0.9
EV/EBITDA-1.4

Leverage

Debt/Equity1.09
Current Ratio4.62
Interest Cov.-3.2x

Quality Scores

Piotroski F2/9
Altman Z-0.76
Beneish M-3.58

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms